Gluten-Free Celiac Disease Patients Experience Fewer Headaches

Article

Giving up bread may not help cure every celiac disease symptom, but researchers found a relationship between a gluten-free diet and a reduction in headache frequency.

Giving up bread may not help cure every celiac disease (CD) symptom, but researchers found a relationship between a gluten-free diet (GFD) and a reduction in the amount of headaches.

The results of an online survey were presented at the 2015 annual meeting of the American Academy of Neurology in Washington, DC. Around 1% of people in the world suffer from CD but there are still questions related to the illness that have yet to be verified.

“Its relation to neurologic disturbances is well demonstrated, while its association with headache and GFD is controversial,” lead author Ameghino LucÍa, of the Neurology Department at FLENI in Buenos Aires, Argentina and his colleagues wrote.

While 1,521 took the questionnaire, only 866 met the criteria. Out of the participants, 24% of them reported headaches as the main symptom after being diagnosed.The chi square test or Mann-Whitney test were used to analyze the survey, based on what was appropriate.

The subjects experienced different types of head pain including tension-type headache (TH, 52%), migraine with aura (MWA, 15.4%), and migraine without aura (MWOA, 32.5%).Upon further examination the researchers revealed that neurological symptoms were more often found in MWA patients than TH.

“Patients with severe headaches tend to have a better compliance to GFD (77%) in comparison to those with milder manifestations (66%),” the investigators explained.

Furthermore, the study revealed that those who complied with the GFD more closely experienced less severe and frequent headaches. Just those with MWA showed a 48% headache frequency improvement when they followed the diet.

“Our results suggest that the strict adhesion to a GFD could have a beneficial outcome amongst celiac patients,” the authors concluded. “However, more studies are required to determine GFD is beneficial for migraine.”

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.